Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gelsemium Sempervirens for Anticipatory Anxiety
NCT00914329Phase 3Completed
- Sponsor
- CHU Grenoble Alpes
- Start
- Jun 2009
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Gelsemium sempervirens, sponsored by CHU Grenoble Alpes. Started Jun 2009; status: completed.
02
Drugs
Gelsemium sempervirens
Beyond the preview
Go deeper on NCT00914329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00914329.